How Much Is ATI Pharmaqua AB Worth?
ATI Pharmaqua AB - Company Valuation
Combines filings, registry risk signals, and versioned market evidence. Learn More ↗ Opens in a New Tab
Enterprise Value
2,247,080 kr
- Range
- 1,647,677 kr–3,979,273 kr
- Evidence StrengthShows how strongly available evidence supports the result. Learn More ↗ Opens in a New Tab
- Low
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- B+
- Risks
- Insufficient Data
Scope & Evidence
- Company
- ATI Pharmaqua AB
- Registration
- SE · 5592565708
- Covers
- Not stated in the filing
- Filings Used
- 6 · FY 2025, 2024, 2023, 2022, 2021, 2020
Industry: NACE 74 · 2 Europe industry cohorts
Methodology & Assumptions
- Industry EV / EBITDA
- 9.1×
- Industry Revenue Multiple
- 1.11×
- Revenue Multiple
- 1.11×
- Enterprise Value
- 2,247,080 kr
- Value Before Discount
- 2,247,080 kr
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- 4.67×
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.27×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- 78.6%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- -
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 31.9%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- 20.7%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- 16.3%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- 10.1%
Liability Maturity
Short-Term
3-Year Revenue Scenarios
3.6m kr
2.7m kr
1.8m kr
900k kr
0 kr
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- emagine Consulting AB
- 634,076,148 kr
- Batteriretur Sverige AB
- 255,913,850 kr
- ATI Pharmaqua AB ★
- 2,238,510 kr
- Jens Ericsson Gastronomi AB
- 1,346,874 kr
- LAK Production AB
- 1,147,551 kr
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
2.6m kr
2m kr
1.3m kr
650k kr
0 kr
20212022202320242025
RevenueNet Profit
Versus Industry Median
2.4m kr
1.8m kr
1.2m kr
600k kr
0 kr
RevenueNet Profit
This CompanyIndustry Median